Here are the quite-encouraging details, overnight:
. . .Gilead said on Monday it had signed royalty-free deals with three generic drugmakers to make its experimental Ebola prevention drug available in 127 mainly low- and lower-middle-income countries if it succeeds in trials and wins regulatory approvals. . . .
The company has donated more than 38,000 remdesivir vials to the Democratic Republic of Congo, Uganda and Kenya, including more than 2,000 recently sent to Kenya for investigational treatment and post-exposure prevention. Remdesivir is not approved to treat or prevent Ebola Bundibugyo disease, and its clinical effectiveness has not been established. . . .
Excellent -- more of this, please. Onward.
And in counterpoint, it must be mentioned that RFK, Jr. (and Trump -- for enabling him) have now presided over almost 8,000 US cases of measles -- and 13 fatalities, from measles. In 2026, alone.
A disease we conquered over five decades ago. Deplorable.
नमस्ते









No comments:
Post a Comment